Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa

被引:48
作者
Gupta, Ankur [1 ]
Wood, Robin [2 ]
Kaplan, Richard [2 ]
Bekker, Linda-Gail [2 ]
Lawn, Stephen D. [1 ,2 ]
机构
[1] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England
[2] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
来源
PLOS ONE | 2013年 / 8卷 / 02期
基金
英国惠康基金; 美国国家卫生研究院;
关键词
HIV-ASSOCIATED TUBERCULOSIS; IMMUNE RECONSTITUTION DISEASE; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; TREATMENT PROGRAM; INFECTED PATIENTS; EARLY OUTCOMES; RURAL UGANDA; ADULTS; DETERMINANTS;
D O I
10.1371/journal.pone.0055824
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes in sub-Saharan Africa have high mortality risk. However, published data are contradictory as to whether TB is a risk factor for mortality that is independent of CD4 cell counts and other patient characteristics. Methods/Findings: This observational ART cohort study was based in Cape Town, South Africa. Deaths from all causes were ascertained among patients receiving ART for up to 8 years. TB diagnoses and 4-monthly CD4 cell counts were recorded. Mortality rates were calculated and Poisson regression models were used to calculate incidence rate ratios (IRR) and identify risk factors for mortality. Of 1544 patients starting ART, 464 patients had prevalent TB at baseline and 424 developed incident TB during a median of 5.0 years follow-up. Most TB diagnoses (73.6%) were culture-confirmed. A total of 208 (13.5%) patients died during ART and mortality rates were 8.84 deaths/100 person-years during the first year of ART and decreased to 1.14 deaths/100 person-years after 5 years. In multivariate analyses adjusted for baseline and time-updated risk factors, both prevalent and incident TB were independent risk factors for mortality (IRR 1.7 [95% CI, 1.2-2.3] and 2.7 [95% CI, 1.9-3.8], respectively). Adjusted mortality risks were higher in the first 6 months of ART for those with prevalent TB at baseline (IRR 2.33; 95% CI, 1.5-3.5) and within the 6 months following diagnoses of incident TB (IRR 3.8; 95% CI, 2.6-5.7). Conclusions: Prevalent TB at baseline and incident TB during ART were strongly associated with increased mortality risk. This effect was time-dependent, suggesting that TB and mortality are likely to be causally related and that TB is not simply an epiphenomenon among highly immunocompromised patients. Strategies to rapidly diagnose, treat and prevent TB prior to and during ART urgently need to be implemented.
引用
收藏
页数:8
相关论文
共 47 条
  • [11] Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B
    Hoffmann, Christopher J.
    Charalambous, Salome
    Thio, Chloe L.
    Martin, Desmond J.
    Pemba, Lindiwe
    Fielding, Katherine L.
    Churchyard, Gavin J.
    Chaisson, Richard E.
    Grant, Alison D.
    [J]. AIDS, 2007, 21 (10) : 1301 - 1308
  • [12] Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline*
    Hosseinipour, M. C.
    Kumwenda, J. J.
    Weigel, R.
    Brown, L. B.
    Mzinganjira, D.
    Mhango, B.
    Eron, J. J.
    Phiri, S.
    van Oosterhout, J. J.
    [J]. HIV MEDICINE, 2010, 11 (08) : 510 - 518
  • [13] The tuberculosis challenge in a rural South African HIV programme
    Houlihan, Catherine F.
    Mutevedzi, Portia C.
    Lessells, Richard J.
    Cooke, Graham S.
    Tanser, Frank C.
    Newell, Marie-Louise
    [J]. BMC INFECTIOUS DISEASES, 2010, 10
  • [14] Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa
    Komati, Stephanus
    Shaw, Pamela A.
    Stubbs, Nomso
    Mathibedi, Monkwe J.
    Malan, Lizette
    Sangweni, Phumelele
    Metcalf, Julia A.
    Masur, Henry
    Hassim, Shaheen
    [J]. AIDS, 2010, 24 (12) : 1849 - 1855
  • [15] Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals
    Lawn, SD
    Bekker, LG
    Miller, RF
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (06) : 361 - 373
  • [16] Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design
    Lawn, SD
    Myer, L
    Orrell, C
    Bekker, LG
    Wood, R
    [J]. AIDS, 2005, 19 (18) : 2141 - 2148
  • [17] Lawn SD, 2011, LANCET INFECT DIS, DOI [10.1016/S1473-3099(1011)70251-70251, DOI 10.1016/S1473-3099(1011)70251-70251]
  • [18] Lawn SD, 2012, AIDS IN PRESS
  • [19] Lawn SD, 2012, 17 INT AIDS C MEX CI, V26, P1730
  • [20] Lawn SD, 2012, AIDS, DOI [10.1097/QAD.1090b1013e3283553685, DOI 10.1097/QAD.1090B1013E3283553685]